Therapy developer Alumis seeks up to $1 billion valuation in US IPO
(Reuters) - Alumis is targeting a valuation of up to $1.01 billion in its initial public offering in the United States, the t...
Jun 24, 2024
G1 Therapeutics' breast cancer drug fails in late-stage trial
(Reuters) - G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal o...
Jun 24, 2024
Alnylam's heart disease drug meets main goal in late-stage study
(Reuters) -Alnylam Pharmaceuticals said on Monday that its drug vutrisiran met the main goal in a late-stage study testing it...
Jun 24, 2024
Doctors must keep prescriptions for Ozempic in check, Danish regulator says
COPENHAGEN (Reuters) - Doctors in Denmark should limit how many packs of Novo Nordisk's Ozempic diabetes drug patients can pi...
Jun 24, 2024
Australia waters down planned world first vape ban after opposition from Greens
By Lewis Jackson SYDNEY (Reuters) - Australia will water down a planned world first ban on vaping after opposition from the G...
Jun 24, 2024
Novo's Wegovy induces higher weight loss in women than men with same heart condition, study shows
By Jacob Gronholt-Pedersen and Bhanvi Satija COPENHAGEN (Reuters) - Novo Nordisk's popular obesity drug Wegovy helped women w...
Jun 23, 2024
Ardent Health discloses over 5% rise in annual revenue in US IPO filing
(Reuters) - Ardent Health Partners disclosed a more than 5% rise in revenue for 2023 on Friday, as the healthcare provider re...
Jun 21, 2024
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
(Reuters) - Amylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' experimental ...
Jun 21, 2024
US FDA approves Roche's drug for a chronic blood disorder
(Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood disorder, the Swiss d...
Jun 21, 2024
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
By Patrick Wingrove (Reuters) - Eli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to sev...
Jun 21, 2024